BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

ARMY MED RES ACQ ACTIVITY

Contract Value

Not provided

Codes & Classification
Solicitation Number

HT9425-23-S-SOC1

NAICS

-

Classification Code

AN12

Additional Details
Set Aside

None

Place of Performance

UNITED STATES

SourceSAM
Documents4
The United States Army Medical Research Acquisition Activity (USAMRAA) has issued a Broad Agency Announcement (BAA), identified as HT9425-23-S-SOC1, to solicit extramural research and development proposals in the field of biomedical and human performance. This initiative is authorized under United States Code, Title 10, Section 4001, and is conducted in accordance with the Competition in Contracting Act of 1984 and relevant Federal Acquisition Regulations (FAR 6.102(d)(2) and 35.016). The BAA is designed to support basic and applied research projects that advance scientific understanding and experimentation, with the overarching goal of enhancing both military and civilian medical knowledge and practice. The scope of this BAA encompasses a wide range of research areas relevant to the United States Special Operations Command (USSOCOM), with a particular emphasis on innovative scientific studies rather than the development of specific systems or hardware solutions. The intended outcomes are to foster advancements in biomedical science and human performance that can inform and improve medical practices across both military and civilian sectors. Key requirements for participation include the mandatory submission of a pre-proposal through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org/. Pre-proposals may be submitted at any time during the BAA’s five-year open period, which runs from August 1, 2023, through July 31, 2028. Upon review of the pre-proposal, if USSOCOM expresses interest, the offeror will be invited to submit a full proposal or application via Grants.gov (http://www.grants.gov/). Detailed instructions for both pre-proposal and full proposal submissions, as well as general administrative information and evaluation criteria, are provided in the "General Submission Instructions" document available on Grants.gov alongside the BAA. The contracting entity for this opportunity is the Army Medical Research Acquisition Activity, a federal office located in the United States (country code: USA). The Product Service Code associated with this notice is AN12, which pertains to research and development in the biomedical domain. The primary point of contact for inquiries is the CDMRP Help Desk, reachable via email at [email protected] or by phone at 301-682-5507. This procurement is classified as a Special Notice and remains active, with all relevant documents and updates accessible through the official SAM.gov opportunity page (https://sam.gov/opp/1942c212a14843a1bedafe79ec8d6dda/view). Contractors interested in this opportunity should note that the BAA is continuously open, allowing for ongoing submission of research ideas throughout the five-year period. The BAA may be revised periodically to update research areas of interest and submission instructions, with all changes available for download on Grants.gov. There are no specified set-aside requirements or special considerations indicated in the notice. The focus is on advancing the state-of-the-art in biomedical and human performance research, with deliverables expected to contribute to scientific knowledge rather than immediate product development. This opportunity is well-suited for organizations with expertise in basic and applied biomedical research seeking to collaborate with the Department of Defense on projects with broad medical impact. In summary, this BAA represents a significant opportunity for research organizations to propose and conduct innovative biomedical and human performance studies that support the mission of USSOCOM and have the potential to benefit both military and civilian healthcare practices over the contract’s lifecycle.